Medical and Behavioral Interventions (drug, device, or procedure; educational, attitudinal, or adherence) |
Patient |
Inconvenience of regimen
Loss of privacy
Poorer health outcomes
Psychosocial discomfort
|
|
Clinician |
Increased time commitment
Additional professional oversight
Decreased confidence/reputation
Decreased clinical autonomy
Increased medical error
|
|
System |
Increased financial costs
Decreased staff/patient satisfaction
Decreased workflow efficiency
Decreased ranking/reputation
New liabilities
|
Decreased financial costs
Improved staff/patient satisfaction
Increased workflow efficiency
Improved ranking/reputation
Better management of liabilities
|
Information Technology Interventions (electronic data management, measurement, or communication) |
Patient |
Increased potential for loss of privacy
Decontextualization of disease
Depersonalization of care and communication
Lower accessibility (limited resources or tech capabilities)
|
Better adherence to regimen
Better health outcomes
Improved continuity of care
Greater access to clinicians
More thorough understanding of disease condition
Better opportunity to report patient-level outcomes
|
Clinician |
Greater security-associated liabilities
Increased frustration and inconvenience
Depersonalization of care
Increased dependence
Insufficient communication or understanding
Increased medical error
|
Increased efficiency and optimization of care delivery
Improved communication accuracy
Improved communication speed
Broadened medical skill set
Decreased medical error
|
System |
Perceived endorsement of experimental technology
Unforeseen stresses to system resources
Incompatibility with existing information technologies
|
Better staffing synergies
Fewer care redundancies
Faster rollout/uptake of system-wide improvements
Better data interoperability
Increased monitoring capabilities
|